Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5884_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Contents
- •1.1 Structure-Based Drug Discovery (SBDD)
- •1.2 Ligand-Based Drug Design (LBDD)
- •1.3 Echoes from the Past, Visions from the Future
- •References
- •1 Introduction
- •2.2 Second Step: Data Curation
- •2.4 Fourth Step: Updating and Maintenance
- •2 Databases and Curation
- •8 Perspectives
- •9 Conclusion
- •References
- •1 Introduction
- •2.1 Making and Matching Protein Models
- •2.2 Simulating Protein Movements
- •2.3 Analyzing Changes in Protein Shape
- •3 Pharmacogenomics in Drug Development
- •4 Case Studies of Genomics-Based Drug Design
- •References
- •1 Historical Background
- •1.1 Timeline
- •2 Methodology Overview
- •2.1 Neural Networks
- •2.1.1 Perceptron
- •2.1.2 Multilayer Neural Networks
- •2.1.3 Types of Neural Networks
- •Feedforward
- •Recurrent Neural Networks
- •LSTM
- •2.2 Deep Learning
- •3 Using Machine Learning
- •3.2 Data Collection
- •3.3 Data Preprocessing
- •3.4 Model Selection
- •3.5 Model Training
- •3.6 Validation
- •3.7 Tuning
- •3.8 Prediction
- •4 Limitations
- •4.1 Bias
- •4.3 Interpretability
- •4.4 Computational Cost
- •4.5 Data Dependency
- •4.6 Robustness
- •5 Applications in Drug Discovery
- •5.2 Lead Discovery
- •5.3 Preclinical and Clinical Development
- •6 Resources and Tools
- •7 Challenges and Perspectives
- •7.1 Future Trends
- •9 Conclusions
- •References
- •1 Historical Background
- •1.1 Applications in Drug Discovery
- •2 Validations and Controls
- •2.1 Internal Validation
- •2.2 External Validation
- •2.3 Relative Cluster Validation
- •3 Challenges and Perspectives
- •4 Conclusions
- •References
- •1 Historical Background
- •2 OECD Principles
- •2.1 A Defined Endpoint
- •2.2 An Unambiguous Algorithm
- •2.5 A Mechanistic Interpretation, if Possible
- •3 Software and Tools
- •4 Validations and Controls
- •4.1 Internal and External Validation
- •4.1.1 Regression Metrics
- •4.2 Applicability Domain
- •4.3 Randomization Tests
- •5 Interpretation
- •6 Practical Advice During QSAR Modeling
- •7 Application
- •8 Challenges and Perspectives
- •References
- •1 Molecular Docking
- •2 Advances in Scoring Functions and Search Algorithms
- •2.2 Critical Characteristics of Search Algorithms
- •2.3 Docking Programs and Scoring Functions
- •3 Calculations Performed During Docking Simulations
- •4 Essential Components for a Good Docking Program
- •5 Limitations of the Docking Technique
- •6 Validation of Docking Results
- •7 Inappropriate Use of Validation Methods in Docking
- •9 Use of Machine Learning in Molecular Docking
- •11 Challenges
- •12 Conclusions
- •References
- •3 System Preparation for MD Simulations
- •3.1 Solvation and Microensemble
- •3.2 Force Fields: General Concept and Relevant Choices
- •3.3 The Concept of Replicas and Timescale
- •4.1.2 Protein Root Mean Square Fluctuation (RMSF)
- •4.1.4 Protein Secondary Structure Analysis
- •4.1.5 Principal component Analysis (PCA)
- •4.1.6 Markov State Modelling
- •4.1.7 Distance Calculations
- •4.1.8 Angle and Plane Calculations
- •4.2.2 Distances and Ligand-Induced Geometry Rearrangements
- •4 Molecular Dynamics Analysis
- •4.1 Protein Perspective
- •4.1.1 Protein Root Mean Square Deviation (RMSD)
- •4.3 Ligand Perspective
- •4.3.1 Ligand Properties
- •4.3.2 Ligand Root Mean Square Deviation
- •4.3.3 Ligand Root Mean Square Fluctuation
- •4.3.4 Angles and Dihedrals
- •5.1 Protein Structure Prediction and Preparation
- •5.2 Molecular Docking
- •6 Concluding Remarks and Outlook
- •Glossary
- •References
- •1 Introduction
- •2.1 MDeNM
- •2.2 Collective Molecular Dynamics (coMD)
- •2.3 ClustENM and ClustENMD
- •3 Ensemble Docking
- •References
- •1 Introduction
- •1.1 Advantages, Disadvantages, Innovations, and Challenges
- •1.2 Recent Advances in Accessible FEP Software Tools
- •1.3 Applications of FEP in Industry and Consortiums
- •2 Expanding the Potential of FEP Calculations
- •2.1 Validating Binding Poses
- •2.2 Dealing with Solvent
- •2.3 FEP and Allostery
- •2.4 FEP and Covalent Ligands
- •2.5 Applications of FEP in Scaffold Hopping
- •2.6 Positional Analogue Scanning
- •2.7 Combinations and Alternative Approaches
- •3 Machine Learning for FEP
- •3.4 Implications for ML in FEP Calculations
- •4 Final Considerations
- •5 First Steps to FEP Simulations
- •References
- •1 Background
- •2 Ultra-Large Screening Libraries and Chemical Spaces
- •3.1 Implications of Dataset Size
- •4 Ligands on the Ultra-Large Scale
- •4.1 Ultra-Large 2D Similarity Searches
- •7 Challenges and Future Perspectives
- •7.1 Hit Triage: An Old Problem on a New Dimension
- •8 Conclusions
- •Appendix
- •References
- •1 Introduction
- •2 Enzymatic Activity Evaluations
- •3 Cytotoxicity Evaluation and Cell Viability
- •4 Antiviral Assays in Experimental Validation
- •6 In Vivo Evaluation of Compounds
- •7 Conclusions
- •References
- •1 Introduction
- •3.1 Data Collection
- •3.2 Data Preprocessing
- •3.4 Model Choice
- •3.5 Model Training
- •3.6 Model Assessment
- •3.7 External Validation
- •3.8 Implementation and Availability
- •3.9 Continuous Update
- •5 Conclusions and Perspectives
- •References
- •1 Experimental Approaches to Obtain Protein Structure
- •1.1 X-Ray Crystallography
- •1.2 Nuclear Magnetic Resonance
- •1.3 Cryo-EM
- •1.4 Hybrid Methods
- •2 Modeling Approaches to Obtain Protein Structure
- •2.1 Homology Modeling
- •2.2 Ab Initio Modeling
- •2.3 New Approaches
- •3 Conformational Diversity of Proteins
- •3.1 Characterization of Protein Conformational States
- •3.2 Experimental Methods to Study Protein Dynamics and Conformations
- •3.4 Molecular Dynamics Simulation
- •3.5 Sampling Strategies
- •4 Remarks and Perspectives
- •References
- •1 Introduction
- •2 Structure-Based Drug Design of HIV Protease Inhibitors
- •2.1 HIV-1 Protease as a Therapeutic Target
- •2.2.1 Saquinavir
- •2.2.2 Indinavir
- •2.3.1 Lopinavir
- •2.3.2 Darunavir
- •6 Conclusions
- •References
- •4 Experimental Methods to Analyze NR Activity
- •4.2 Coregulator-Recruitment
- •5 Concluding Remarks and Outlook
- •References

14 Exploring the Significance of Experimental and Computational Methods .. . 419
The initial step in MD simulations is selecting the file with the protein coordinates
(i.e., the structure with the highest resolution of atomic coordinates). Depending on
the experimental structural elucidation technique, not all atomic coordinates are
resolved, and there may be regions (gaps) without structural definition. However,
it is possible to use programs that perform structural comparisons of proteins and, by
similarity, complete the lacking regions, such as SWISS-MODEL [71]. Some MD
simulation software includes routines for preparing input files to perform this
verification and reconstruction of missing residues, such as the AMBERtools
[136]. Other aspects that require attention when conducting an MD simulation are
the definition of the statistical ensemble, the control of temperature and pressure, the
initial energy minimization conditions and system equilibration, the use of periodic
boundary conditions, the minimum image convention and cutoff radius, the treatment of long-range interactions, and the application of solvation methods for the
system [54]. Thus, once the parameters and conditions are obtained, the calculation
begins, proceeding through the minimization, heating, and production stages in a
classical MD simulation [116, 137].
More details on methodological aspects, validations, and analysis of MD simulations can be found in Chap. 8.
3.5 Sampling Strategies
According to Newton’s classical physics equations, several MD approaches are
successfully used to study the interaction and movement of atoms and molecules.
The numerical integration of Newton’s equations of motion for a system of
interacting particles provides successive system configurations, like a trajectory
film, showing the particles’ positions and velocities over a predetermined fixed
time. However, MD simulations require many numerical calculations due to the
small integration time steps of femtoseconds (10
simulate biologically relevant events (such as protein folding below microseconds,
-6
10
s) [138 ].
-15
s), which are necessary to
MD simulations have become an important and widespread method to explore
conformational space, being applied to studying the folding of small proteins
(around 80 amino acids) in their native structures [139]. Along with the precision
and robustness of diverse types of force fields (including solvent models), an aspect
that initially limits the e xtent of sampling in MD applications is the time scale a
conventional MD simulation can achieve. Typically, they are very short in describing real problems of protein systems with hundreds of thousands of atoms.
Several enhanced computational methods have been developed to address these
sampling issues using MD and expand the sampling range of classical MD simulations. Among these methods, one can include replica-exchange MD simulations
[140], steered MD [141], accelerated MD [142], metadynamics [143], and adaptive

420 A. H. Moraes et al.
steered MD [79]. Some methods use constrained potentials over force constants to
direct sampling over energy barriers and pre-defined reaction coordinates, as in
umbrella samplin g [144] and metadynamics [145]. However, these methods restrict
their use in predicting actual structures since the endpoint must be unknown in a
protein folding study. As an alternative, sampling methods that use energy as a
reaction coordinate have been developed, generalized ensemble methods such as
replica exchange MD (REMD), and methods that combine both methodologies
[146]. The REMD has becom e one of the most popular ab initio methodologies
for simulating protein folding, as it allows multi-node parallel computing architectures. In addition, the method can be used with stochastic Monte Carlo
simulations [147].
One can highlight some applications in this context, such as the ab initio structure
prediction of peptides and small proteins. Peptides have enormous potential for drug
development, bridging between small molecule-based drugs and proteins
[148]. Many naturally occurring peptides or those designed by computational
modeling have had their 3D structures predicted by MD-based methods. However,
peptide modeling via MD-base methods with sequence alignment is less reliable
than proteins [138].
3.6 Impact of Protein Structure and Dynamics on Drug
Design
The binding of proteins and ligands relies on physical and chemical interactions
between residues in the binding site of the protein and the ligand, ensuring specificity
and communication between active and allosteric sites. These interactions induce
structural changes in the binding pocket as the protein transitions from its ligandunbound (apo) to ligand-bound (holo) state, causing many differences between apo
and holo structures [149 ].
A study from 2005 examined 60 enzymes, revealing structural discrepancies
between their apo and holo forms [150]. However, most of the enzymes displayed
minimal deviations (≤1Å)inCα root mean square deviation (RMSD) between the
two states, their apo and holo states. Subsequently, in 2007 [151], 98 apo-holo pairs
were categorized into rigid, moderate, and flexible categories based on Cα RMSD
differences, highlighting preferences for polar–polar interactions in rigid proteins
and hydrophobic interactions in flexible ones. Exploring side chain orientations
across apo–holo pairs revealed increased flexibility at the binding site, often
overlooked in analyses focusing solely on residue backbones. Nevertheless, significant disparities can become apparent when analyzing side chain orientations across
apo–holo pairs [152]. One of the most visualized conformational changes upon
binding is the side chain rotameric stat e changes [153, 154].
The consensus from various studies suggests that while backbones undergo minor
conformational chang es, side chains explore a broader conformational space upon
ligand binding [149]. Consequently, holo-structures are generally preferred targets
for ligand docking due to differences in binding site structures. Holo-structure

14 Exploring the Significance of Experimental and Computational Methods .. . 421
superiority over apo counterparts was demonstrated in discriminating binders from
nonbinders [155], whereas significantly lower enrichment levels were observed in
apo structures compared to their holo counterparts [156]. Based on that information,
computational simulation for drug design methods that account for sidechain flexibility and multiple receptor conformations becomes crucial. Flexible SLIDE
docking can accommodate ligands within 2.5 Å of their crystal structure pose by
manipulating sidechain orientations in apo structures to address the challenges
associated with rigid docking [157]. While flexible docking offers a solution, proteins with significant backbone differences pose challenges. Ensemble docking,
employing MD simulations to obtain multiple receptor conformations, offers an
alternative approach [158, 159].
Furthermore, considering the available structural information of the system under
study is important for simulations. Molecular docking typically yields optimal
results when the molecule resembles the one crystallized [160 ]; RMSD <2.0 Å
corresponds to good docking simulations. However, achieving such similarity is not
always possible. In efforts to facilitate virtual screening using apo structures, protocols involving MD simulations to refine prote in structures were developed and
could be implemented before the virtual screening procedure. This strategy is
especially helpful when holo-structures are unavailable [149].
However, inherent flaws in current scoring functions, such as excessive simplifications, limited consideration of interaction energies, inaccuracies in predicting
binding affinities, may compromise the accurate identification of the putative binding mode of simulated compounds (docking poses), improper consideration of
oligomerization states, or the presence of multiple interfaces typically excluded
from docking calculations [161–163]. To mitigate these challenges, leveraging
external information whenever feasible and available can enhance the accuracy of
docking predictions. Pioneering methods like HADDOCK [164] and other protein–
protein docking approaches like pyDock [165], ZDOCK [166], and LightD ock [167]
have implemented protocols incor porating distance restraints to refine docking
calculations.
Although most enzymes do not undergo significant conformational changes when
interacting with a ligand, as previously discussed, understanding the system to be
modeled is always beneficial in selecting the appropriate structures. One example is
Abelson kinase (Abl), an enzyme whose deregulation causes chronic myeloid
leukemia and can exhibit different conformations depending on the ligand
[168]. Some inhibitors, such as dasatinib, inhibit an active form of the enzyme, in
which the activation segment is in an open conformation (Fig. 14.4). In contrast,
imatinib inhibits an inactive conformation of the protein, where the activation
segment is in a closed conformation. Due to steric effects, imatinib cannot bind to
the enzyme when the activation segment is in the extended conformation. Additionally, the activation segment’s conformation influences the P-loop conformation,
which must adopt a folded conformation when the activation segment closes to
avoid electrostatic repulsion [169, 170]. So, a detailed understanding of the conformations and specific interactions of ligands with enzym es is essential for selecting

422 A. H. Moraes et al.
Fig. 14.4 Superposition of Abl structures co-crystallized with imatinib in blue (PDB ID 2HYY)
and dasatinib in brown (PDB ID 2GQG). Residues with potential steric hindrance, depending on the
conformational state of the activation segment and P-loop, are shown [169, 170]. These steric
hindrances are highlighted as dotted spheres in yellow. The figure was generated using the software
PyMOL
and preparing the correct structures in computational simulations, directly influencing the accuracy and effectiveness of docking and molecular dynamics studies.
4 Remarks and Perspectives
In conclusion, integrating experimental and computational techniques is essential for
advancing drug design, particularly in understanding protein structure and dynamics.
The impact of conformational diversity between apo and holo states underscores the
need for comprehensive methods that capture the full range of structural variability.
Experimental methods provide critical insights into these structural changes, while
computational techniques, such as flexible docking and ensemble docking, address
the challenges of conformational flexibility. By combining these approaches,
researchers can enhance the accuracy of ligand binding predictions and better
understand the dynamic nature of protein–ligand interactions. This synergy between
experimental and computational strategies is crucial for developing effective therapeutics and optimizing drug discovery processes.
Moreover, we are at a transformative juncture in structural biology and protein
modeling with the advent of powerful tools like AlphaFold and RoseTTAFold.

14 Exploring the Significance of Experimental and Computational Methods .. . 423
These groundbreaking technologies have dramatically improved our ability to predict protein structures with unprecedented accuracy, which in turn, is set to influence
experimental techniques such as X-ray crystallography, NMR, and cryo-EM. As
these computational methods continue to evolve, they will complement and refine
traditional experimental approaches, thereby accelerating discoveries and deepening
our understanding of complex biomolecular systems. This convergence of computational and experimental strategies marks a new era in structural biology, promising
significant advancements in fundamental research and drug development.
References
1. Hong, S. H., Joung, I., Flores-Canales, J. C., Manavalan, B., Cheng, Q., Heo, S., Kim, J. Y.,
Lee, S. Y., Nam, M., Joo, K., et al. (2018). Protein structure modeling and refinement by global
optimization in CASP12. Proteins: Structure, Function, and Bioinformatics, 86(S1), 122–135.
2. Kendrew, J. C., Bodo, G., Dintzis, H. M., Parrish, R. G., Wyckoff, H., & Phillips, D. C.
(1958). A three-dimensional model of the myoglobin molecule obtained by X-ray analysis.
Nature, 181(4610), 662–666.
3. Perutz, M. F., Rossmann, M. G., Cullis, A. F., Muirhead, H., Will, G., & North,
A. C. T. (1960). Structure of hæmoglobin: A three-dimensional Fourier synthesis at 5.5-Å.
Resolution, obtained by X-ray analysis. Nature, 185(4711), 416–422.
4. Aue, W. P., Bartholdi, E., & Ernst, R. R. (1976). Two-dimensional spectroscopy. Application
to nuclear magnetic resonance. The Journal of Chemical Physics, 64(5), 2229 – 2246.
5. Williamson, M. P., Havel, T. F., & Wüthrich, K. (1985). Solution conformation of proteinase
inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance
geometry. Journal of Molecular Biology, 182(2), 295–315.
6. Palmer, A. G., & Massi, F. (2006). Characterization of the dynamics of biomacromolecules
using rotating-frame spin relaxation NMR spectroscopy. Chemical Reviews, 106(5),
1700–1719.
7. Jiang, W., Baker, M. L., Jakana, J., Weigele, P. R., King, J., & Chiu, W. (2008). Backbone
structure of the infectious Ε15 virus capsid revealed by electron cryomicroscopy. Nature,
451(7182), 1130–1134.
8. Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T. C., Rossmann, M. G., & Kuhn, R. J.
(2016). The 3.8 Å resolution Cryo-EM structure of Zika virus. Science, 352(6284), 467–470.
9. Beckers, M., Mann, D., & Sachse, C. (2021). Structural interpretation of Cryo-EM image
reconstructions. Progress in Biophysics and Molecular Biology, 160,26–36.
10. Zhang, X., Settembre, E., Xu, C., Dormitzer, P. R., Bellamy, R., Harrison, S. C., & Grigorieff,
N. (2008). Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction. Proceedings of the National Academy of Sciences, 105(6), 1867–1872.
11. Berman, H., Henrick, K., & Nakamura, H. (2003). Announcing the worldwide protein data
Bank. Nature Structural & Molecular Biology, 10(12), 980–980.
12. Ilari, A., & Savino, C. (2008). Protein structure determination by X-Ray. Crystallography,
63–87.
13. McPherson, A., & Gavira, J. A. (2014). Introduction to protein crystallization. Acta
Crystallographica Section F: Structural Biology and Crystallization Communications,
70(1), 2–20.
14. Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N.,
Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., et al. (2018). MolProbity: More and better
reference data for improved all-atom structure validation. Protein Science, 27(1), 293–315.

424 A. H. Moraes et al.
15. Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). Procheck: A
program to check the stereochemical quality of protein structures. Journal of Applied Crys-
tallography, 26(2), 283–291.
16. Almeida, F. C. L. F. C. L., Moraes, A. H. A. H., & Gomes-Neto, F. (2013). No title (Vol.
9781461451, pp. 377–412). Springer.
17. Fernandez, C. (2003). TROSY in NMR studies of the structure and function of large biological
macromolecules. Current Opinion in Structural Biology, 13(5), 570–580.
18. Charlier, C., Cousin, S. F., & Ferrage, F. (2016). Protein dynamics from nuclear magnetic
relaxation. Chemical Society Reviews, 45(9), 2410–2422.
19. Almeida, F. C. L., Moraes, A. H., & Gomes-Neto, F. (2013). An overview on protein structure
determination by NMR: Historical and future perspectives of the use of distance geometry
methods. In Distance geometry (pp. 377–412). Springer.
20. Moraes, A. H., & Valente, A. P. (2023). Conformational dynamics and kinetics of protein
interactions by nuclear magnetic resonance. Journal of Magnetic Resonance Open, 14–15,
100093.
21. Moraes, A. H., Ackerbauer, D., Kostadinova, M., Bublin, M., de Oliveira, G. A., Ferreira,
F. F., Almeida, F. C. L. C., Breiteneder, H., Valente, A. P., de Oliveira, G. A., et al. (2014).
Solution and high-pressure NMR studies of the structure, dynamics, and stability of the crossreactive allergenic cod parvalbumin Gad m 1. Proteins: Structure, Function, and Bioinfor-
matics, 82(11), 3032–3042.
22. Moraes, A. H. H., Asam, C., Batista, A., Almeida, F. C. L. C. L. L., Wallner, M., Ferreira, F.,
& Valente, A. P. P. (2016). 1H, 13C and 15N resonance assignments and second structure
information of Fag s 1: Fagales allergen from Fagus Sylvatica. Biomolecular NMR Assign-
ments, 10(1), 45–48.
23. Moraes, A. H., Asam, C., Almeida, F. C. L. L., Wallner, M., Ferreira, F., & Valente, A. P.
(2018). Structural basis for cross-reactivity and conformation fluctuation of the major beech
pollen allergen fag s 1. Scientific Reports, 8(1), 10512.
24. Güntert, P. (2004). Automated NMR structure calculation with CYANA. Methods in Molec-
ular Biology (Clifton, N.J.), 278(4), 353–378.
25. Linge, J. P., Habeck, M., Rieping, W., & Nilges, M. (2003). ARIA: Automated NOE
assignment and NMR structure calculation. Bioinformatics, 19(2), 315–316.
26. Shen, Y., & Bax, A. (2013). Protein backbone and sidechain torsion angles predicted from
NMR chemical shifts using artificial neural networks. Journal of Biomolecular NMR, 56(3),
227–241.
27. Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996). AQUA
and PROCHECK-NMR: Programs for checking the quality of protein structures solved by
NMR. Journal of Biomolecular NMR, 8(4).
28. Bhattacharya, A., Tejero, R., & Montelione, G. T. (2007). Evaluating protein structures
determined by structural genomics consortia. Proteins: Structure, Function, and Bioinformat-
ics, 66(4), 778–795.
29. Doreleijers, J. F., Sousa da Silva, A. W., Krieger, E., Nabuurs, S. B., Spronk, C. A. E. M.,
Stevens, T. J., Vranken, W. F., Vriend, G., & Vuister, G. W. (2012). CING: An integrated
residue-based structure validation program suite. Journal of Biomolecular NMR, 54(3),
267–283.
30. Fernandez-Leiro, R., & Scheres, S. H. W. (2016). Unravelling biological macromolecules with
cryo-electron microscopy. Nature, 537(7620), 339–346.
31. Callaway, E. (2015). The revolution will not be crystallized: A new method sweeps through
structural biology. Nature, 525(7568), 172–174.
32. Weissenberger, G., Henderikx, R. J. M., & Peters, P. J. (2021). Understanding the invisible
hands of sample preparation for cryo-EM. Nature Methods, 18(5), 463–471.
33. Zhong, E. D., Bepler, T., Berger, B., & Davis, J. H. (2021). CryoDRGN: Reconstruction of
heterogeneous cryo-EM structures using neural networks. Nature Methods, 18(2), 176–185.

14 Exploring the Significance of Experimental and Computational Methods .. . 425
34. Thompson, R. F., Walker, M., Siebert, C. A., Muench, S. P., & Ranson, N. A. (2016). An
introduction to sample preparation and imaging by cryo-electron microscopy for structural
biology. Methods, 100,3–15.
35. Yip, K. M., Fischer, N., Paknia, E., Chari, A., & Stark, H. (2020). Atomic-resolution protein
structure determination by Cryo-EM. Nature, 587(7832), 157–161.
36. Nakane, T., Kotecha, A., Sente, A., McMullan, G., Masiulis, S., Brown, P. M. G. E., Grigoras,
I. T., Malinauskaite, L., Malinauskas, T., Miehling, J., et al. (2020). Single-particle Cryo-EM
at atomic resolution. Nature, 587(7832), 152–156.
37. Chen, M., Schmid, M. F., & Chiu, W. (2024). Improving resolution and resolvability of singleparticle CryoEM structures using Gaussian mixture models. Nature Methods, 21(1), 37–40.
38. Miller, M. D., & Phillips, G. N. (2021). Moving beyond static snapshots: Protein dynamics
and the protein data Bank. The Journal of Biological Chemistry, 296, 100749.
39. Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J.,
Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017). Cryo-EM structures of
tau filaments from Alzheimer’s disease. Nature, 547(7662), 185–190.
40. Gremer, L., Schölzel, D., Schenk, C., Reinartz, E., Labahn, J., Ravelli, R. B. G., Tusche, M.,
Lopez-Iglesias, C., Hoyer, W., Heise, H., et al. (2017). Fibril structure of amyloid-β(1–42) by
cryo–electron microscopy. Science (80-. ), 358(6359), 116–119.
41. Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham,
B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-NCoV spike in the prefusion
conformation. Science (80-. ), 367(6483), 1260–1263.
42. Xie, M., Yu, L., Bruschweiler-Li, L., Xiang, X., Hansen, A. L., Brüschweiler, R., Kastritis,
P. L., Bonvin, A. M. J. J., Wallerstein, J., Akke, M., et al. (2019). Measuring dynamic and
kinetic information in the previously inaccessible supra-Τc window of nanoseconds to microseconds by solution NMR spectroscopy. Journal of Biomolecular NMR, 52(1), 139–148.
43. Cheng, Y. (2018). Membrane protein structural biology in the era of single particle Cryo-EM.
Current Opinion in Structural Biology, 52,58–63.
44. Piper, S. J., Johnson, R. M., Wootten, D., & Sexton, P. M. (2022). Membranes under the
magnetic lens: A dive into the diverse world of membrane protein structures using Cryo-EM.
Chemical Reviews, 122(17), 13989–14017.
45. Sun, C., Zhu, H., Clark, S., & Gouaux, E. (2023). Cryo-EM structures reveal native GABAA
receptor assemblies and pharmacology. Nature, 622(7981), 195–201.
46. Carroni, M., & Saibil, H. R. (2016). Cryo electron microscopy to determine the structure of
macromolecular complexes. Methods, 95,78–85.
47. Kyrilis, F. L., Belapure, J., & Kastritis, P. L. (2021). Detecting protein communities in native
cell extracts by machine learning: A structural Biologist’s perspective. Frontiers in Molecular
Biosciences, 8, 229.
48. Verbeke, E. J., Gilles, M. A., Bendory, T., & Singer, A. (2024). Self Fourier Shell correlation:
Properties and application to Cryo-ET. Communications Biology, 7(1), 101.
49. Lawson, C. L., Kryshtafovych, A., Adams, P. D., Afonine, P. V., Baker, M. L., Barad, B. A.,
Bond, P., Burnley, T., Cao, R., Cheng, J., et al. (2021). Cryo-EM model validation recommendations based on outcomes of the 2019 EMDataResource challenge. Nature Methods,
18(2), 156–164.
50. Schneidman-Duhovny, D., & Hammel, M. (2018). Modeling Structure and Dynamics of
Protein Complexes with SAXS Profiles. Methods in Molecular Biology, 178, 449–473.
51. Mertens, H. D. T., & Svergun, D. I. (2017). Combining NMR and small angle X-ray scattering
for the study of biomolecular structure and dynamics. Archives of Biochemistry and Biophys-
ics, 628,33–41.
52. Masson, G. R., Burke, J. E., Ahn, N. G., Anand, G. S., Borchers, C., Brier, S., Bou-Assaf,
G. M., Engen, J. R., Englander, S. W., Faber, J., et al. (2019). Recommendations for
performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry
(HDX-MS) experiments. Nature Methods, 16(7), 595–602.

426 A. H. Moraes et al.
53. O’Reilly, F. J., & Rappsilber, J. (2018). Cross-linking mass spectrometry: Methods and
applications in structural, molecular and systems biology. Nature Structural & Molecular
Biology, 25(11), 1000–1008.
54. Lee, J., Freddolino, P. L., & Zhang, Y. (2017). Ab initio protein structure prediction. In From
protein structure to function with bioinformatics (pp. 3–35). Springer.
55. Torrisi, M., Pollastri, G., & Le, Q. (2020). Deep learning methods in protein structure
prediction. Computational and Structural Biotechnology Journal, 18, 1301–1310.
56. Li, W., Wang, W., & Takada, S. (2014). Energy landscape views for interplays among folding,
binding, and Allostery of Calmodulin domains. Proceedings of the National Academy of
Sciences of the United States of America, 111(29), 10550–10555.
57. Das, R., Kretsch, R. C., Simpkin, A. J., Mulvaney, T., Pham, P., Rangan, R., Bu, F., Keegan,
R. M., Topf, M., Rigden, D. J., et al. (2023). Assessment of three-dimensional RNA structure
prediction in CASP15. Proteins Struct. Funct. Bioinforma, 91(12), 1747–1770.
58. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O.,
Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021). Highly accurate
protein structure prediction with AlphaFold. Nature, 596(7873), 583–589.
59. Chothia, C., & Lesk, A. M. (1986). The relation between the divergence of sequence and
structure in proteins. The EMBO Journal, 5(4), 823–826.
60. Sander, C., & Schneider, R. (1991). Database of homology-derived protein structures and the
structural meaning of sequence alignment. Proteins: Structure, Function, and Bioinformatics,
9(1), 56–68.
61. Yang, Y., Faraggi, E., Zhao, H., & Zhou, Y. (2011). Improving protein fold recognition and
template-based modeling by employing probabilistic-based matching between predicted
one-dimensional structural properties of query and corresponding native properties of templates. Bioinformatics, 27(15), 2076–2082.
62. Koonin, E. V. (2005). Orthologs, paralogs, and evolutionary genomics. Annual Review of
Genetics, 39(1), 309–338.
63. Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000).
Comparative protein structure modeling of genes and genomes. Annual Review of Biophysics
and Biomolecular Structure, 29(1), 291–325.
64. Tramontano, A. (1998). Homology modeling with low sequence identity. Methods, 14(3),
293–300.
65. Arganda-Carreras, I., Kaynig, V., Rueden, C., Eliceiri, K. W., Schindelin, J., Cardona, A., &
Sebastian Seung, H. (2017). Trainable Weka segmentation: A machine learning tool for
microscopy pixel classification. Bioinformatics, 33(15), 2424–2426.
66. Hameduh, T., Haddad, Y., Adam, V., & Heger, Z. (2020). Homology modeling in the time of
collective and artificial intelligence. Computational and Structural Biotechnology Journal, 18
3494–3506.
67. Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E.,
Bowler-Barnett, E. H., Britto, R., Bursteinas, B., et al. (2021). UniProt: The universal protein
knowledgebase in 2021. Nucleic Acids Research, 49(D1), D480–D489.
68. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H.,
Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007). Clustal W and Clustal X
version 2.0. Bioinformatics, 23(21), 2947–2948.
69. Li, W., Cowley, A., Uludag, M., Gur, T., McWilliam, H., Squizzato, S., Park, Y. M., Buso, N.,
& Lope z, R. (2015). The EMBL-EBI bioinformatics web and programmatic tools framework.
Nucleic Acids Research, 43(W1), W580–W584.
70. Edgar, R. C. (2004). Muscle: Multiple sequence alignment with high accuracy and high
throughput. Nucleic Acids Research, 32(5), 1792–1797.
71. Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T.,
de Beer, T. A. P., Rempfer, C., Bordoli, L., et al. (2018). Swiss-model: Homology modelling
of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303.
,

14 Exploring the Significance of Experimental and Computational Methods .. . 427
72. Xu, G., Ma, T., Du, J., Wang, Q., & Ma, J. (2019). OPUS-Rota2: An improved fast and
accurate side-chain modeling method. Journal of Chemical Theory and Computation, 15(9),
5154–5160.
73. Wang, Q., Canutescu, A. A., & Dunbrack, R. L. (2008). SCWRL and MolIDE: Computer
programs for side-chain conformation prediction and homology modeling. Nature Protocols,
3(12), 1832–1847.
74. Huang, X., Pearce, R., & Zhang, Y. (2020). FASPR: An open-source tool for fast and accurate
protein side-chain packing. Bioinformatics, 36(12), 3758–3765.
75. Ekman, D., Björklund, Å. K., Frey-Skött, J., & Elofsson, A. (2005). Multi-domain proteins in
the three kingdoms of life: Orphan domains and other unassigned regions. Journal of Molec-
ular Biology, 348(1), 231–243.
76. Meier, A., & Söding, J. (2015). Automatic prediction of protein 3D structures by probabilistic
multi-template homology modeling. PLoS Computational Biology, 11(10), e1004343.
77. Xiang, Z. (2006). Advances in homology protein structure modeling. Current Protein &
Peptide Science, 7(3), 217–227.
78. Liang, S., & Grishin, N. V. (2002). Side-chain modeling with an optimized scoring function.
Protein Science, 11(2), 322–331.
79. Ozer, G., Quirk, S., & Hernandez, R. (2012). Adaptive steered molecular dynamics: Validation of the selection criterion and benchmarking energetics in vacuum. The Journal of
Chemical Physics, 136 (21).
80. Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J.,
Cong, Q., Kinch, L. N., Schaeffer, R. D., et al. (2021). Accurate prediction of protein
structures and interactions using a three-track neural network. Science (80-. ), 373(6557),
871–876.
81. Böhm, G. (1996). New approaches in molecular structure prediction. Biophysical Chemistry,
59(1–2), 1–32.
82. Kwon, S., Won, J., Kryshtafovych, A., & Seok, C. (2021). Assessment of protein model
structure accuracy estimation in CASP14: Old and new challenges. Proteins Structure Func-
tion and Bioinformatics, 89(12), 1940–1948.
83. Robin, X., Haas, J., Gumienny, R., Smolinski, A., Tauriello, G., & Schwede, T. (2021).
Continuous Automated Model EvaluatiOn (CAMEO)—Perspectives on the future of fully
automated evaluation of structure prediction methods. Proteins Structure Function and Bio-
informatics, 89(12), 1977–1986.
84. Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., Qin, C., Žídek, A.,
Nelson, A. W. R., Bridgland, A., et al. (2020). Improved protein structure prediction using
potentials from deep learning. Nature, 577(7792), 706–710.
85. Pereira, J., Simpkin, A. J., Hartmann, M. D., Rigden, D. J., Keegan, R. M., & Lupas, A. N.
(2021). High-accuracy protein structure prediction in CASP14. Proteins Structure Function
and Bioinformatics, 89(12), 1687–1699.
86. Valente, A., Miyamoto, C., Almeida, L., & F. (2006). Implications of protein conformational
diversity for binding and development of new biological active compounds. Current Medic-
inal Chemistry, 13
87. Wei, G., Xi, W., Nussinov, R., & Ma, B. (2016). Protein ensembles: How does nature harness
thermodynamic fluctuations for life? The diverse functional roles of conformational ensembles
in the cell. Chemical Reviews, 116(11), 6516–6551.
88. Trivedi, R., & Nagarajaram, H. A. (2022). Intrinsically disordered proteins: An overview.
International Journal of Molecular Sciences, 23(22), 14050.
89. Tsai, C., Ma, B., Sham, Y. Y., Kumar, S., & Nussinov, R. (2001). Structured disorder and
conformational selection. Proteins Structure Function and Bioinformatics, 44(4), 418–427.
90. Carlson, G. M., & Fenton, A. W. (2016). What mutagenesis can and cannot reveal about
Allostery. Biophysical Journal, 110(9), 1912–1923.
(30), 3697–3703.

428 A. H. Moraes et al.
91. Petit, C. M., Zhang, J., Sapienza, P. J., Fuentes, E. J., & Lee, A. L. (2009). Hidden dynamic
Allostery in a PDZ domain. Proceedings of the National Academy of Sciences, 106(43),
18249–18254.
92. Thirumalai, D., Hyeon, C., Zhuravlev, P. I., & Lorimer, G. H. (2019). Symmetry, rigidity, and
allosteric signaling: From monomeric proteins to molecular machines. Chemical Reviews,
119(12), 6788–6821.
93. Papaleo, E., Saladino, G., Lambrughi, M., Lindorff-Larsen, K., Gervasio, F. L., & Nussinov,
R. (2016). The role of protein loops and linkers in conformational dynamics and Allostery.
Chemical Reviews, 116(11), 6391–6423.
94. Lindner, A. B., Eshhar, Z., & Tawfik, D. S. (1999). Conformational changes affect binding and
catalysis by Ester-hydrolysing antibodies 1 1Edited by. Journal of Molecular Biology, 285(1),
421–430.
95. Shumilin, I. A., Cymborowski, M., Chertihin, O., Jha, K. N., Herr, J. C., Lesley, S. A.,
Joachimiak, A., & Minor, W. (2012). Identification of unknown protein function using
metabolite cocktail screening. Structure, 20(10), 1715–1725.
96. Earl, L. A., Falconieri, V., Milne, J. L., & Subramaniam, S. (2017). Cryo-EM: Beyond the
microscope. Current Opinion in Structural Biology, 46,71–78.
97. Palmer, A. G. (2015). Enzyme dynamics from NMR spectroscopy. Accounts of Chemical
Research, 48(2), 457–465.
98. Palmer, A. G. (2016). A dynamic look backward and forward. Journal of Magnetic Reso-
nance, 266,73–80.
99. Tzeng, S. R., & Kalodimos, C. G. (2011). Protein dynamics and Allostery: An NMR view.
Current Opinion in Structural Biology, 21(1), 62–67.
100. Byer, A. S., Pei, X., Patterson, M. G., & Ando, N. (2023). Small-angle X-ray scattering studies
of enzymes. Current Opinion in Chemical Biology, 72, 102232.
101. Gräwert, T. W., & Svergun, D. I. (2020). Structural modeling using solution small-angle X-ray
scattering (SAXS). Journal of Molecular Biology, 432(9), 3078–3092.
102. Jacques, D. A., & Trewhella, J. (2010). Small-angle scattering for structural biology—
Expanding the frontier while avoiding the pitfalls. Protein Science, 19(4), 642–657.
103. Da Vela, S., & Svergun, D. I. (2020). Methods, development and applications of small-angle
X-ray scattering to characterize biological macromolecules in solution. Current Research in
Structural Biology, 2, 164–170.
104. Trewhella, J. (2022). Recent advances in small-angle scattering and its expanding impact in
structural biology. Structure, 30(1), 15–23.
105. Edwards, D. T., LeBlanc, M.-A., & Perkins, T. T. (2021). Modulation of a protein-folding
landscape revealed by AFM-based force spectroscopy notwithstanding instrumental limitations. Proceedings of the National Academy of Sciences, 118 (12).
106. Jahn, M., Buchner, J., Hugel, T., & Rief, M. (2016). Folding and assembly of the large
molecular machine Hsp90 studied in single-molecule experiments. Proceedings of the
National Academy of Sciences, 113
107. Liu, T., Khanal, S., Hertslet, G. D., & Lamichhane, R. (2023). Single-molecule analysis
reveals that a glucagon-bound extracellular domain of the glucagon receptor is dynamic.
The Journal of Biological Chemistry, 299(9), 105160.
108. Schuler, B., & Hofmann, H. (2013). Single-molecule spectroscopy of protein folding
dynamics—Expanding scope and timescales. Current Opinion in Structural Biology, 23(1),
36–47.
109. Neupane, K., Yu, H., Foster, D. A. N., Wang, F., & Woodside, M. T. (2011). Single-molecule
force spectroscopy of the add adenine riboswitch relates folding to regulatory mechanism.
Nucleic Acids Research, 39(17), 7677–7687.
110. Halma, M. T. J., Tuszynski, J. A., & Wuite, G. J. L. (2023). Optical tweezers for drug
discovery. Drug Discovery Today, 28(1), 103443.
111. Sharma, S., Singh, V., & Biswas, P. (2021). Effect of ligand binding on riboswitch folding:
Theory and simulations. The Journal of Chemical Physics, 154(18).
(5), 1232–1237.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
